Compound betamethasone

ApprovedSmall molecule

SSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Compound betamethasone is one of 72 small molecule programs targeting Granuloma. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

GranulomaActive, not recruiting

ArthritisActive, not recruiting

Frozen ShoulderActive, not recruiting

Sarcoidosis, PulmonaryNot yet recruiting

GranulomaApproved

Active, not recruiting

ArthritisPhase 2

Active, not recruiting

Frozen ShoulderApproved

Active, not recruiting

Sarcoidosis, PulmonaryPreclinical

Not yet recruiting

Competition

Competitive Landscape

159 competitors in Arthritis

#DrugCompanyPhaseTrials

Cosentyx

Novartis

Phase 3

9 2

Simponi

Johnson & Johnson

Phase 3

6 3

Taltz

Eli Lilly

Phase 3

5 4

Aleve

Alnylam Pharmaceuticals

Phase 3

4 5

Stelara

Johnson & Johnson

Phase 3

3 6

Bimzelx

UCB

Phase 3

2 7

Ilaris

Novartis

Phase 3

2 8

Compound betamethasone

SSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Approved

1 9

Remicade

OOrganon and Co

Phase 3

3 10

Kenalog

BBassett Healthcare

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Phase 2Not yet recruiting

Arthritis

NCT07453004

Q3 2028

PreclinicalNot yet recruiting

Sarcoidosis, Pulmonary

NCT07668895

Q4 2028

N/ARecruiting

Injury

NCT07348016

Q1 2031

Post-ApprovalRecruiting

Frozen Shoulder

NCT07416916

Clinical

Trials by Indication[1]

Frozen Shoulder3 trials

Comparison Between Subacromial Ultrasound Guided and Systemic Steroid Injection for Frozen Shoulder

Terminated·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Phase 4·NCT04931511·20 enrolled

Ultrasound-Guided Intra-Articular vs Gluteal Intramuscular Corticosteroid Injection for Frozen Shoulder

Recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Phase 4·NCT07416916·528 enrolled

Comparison Between Ultrasound Guided Subacromial and Systemic Injection of Steroid for Frozen Shoulder: a Double Blind Multicenter Pilot Study for Randomized Control Trial

Completed·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Phase 2·NCT06626568·40 enrolled

Monoclonal2 trials

A Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout

Unknown status·SSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.·Phase 3·NCT06169891·500 enrolled

A Phase Ib/II Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout

Unknown status·SSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.·Phase 1/2·NCT05588908·120 enrolled

Arthritis1 trial

A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis

Not yet recruiting·TTJ Biopharma Co., Ltd.·Phase 2·NCT07453004·170 enrolled

Mesenchymal Stem Cells1 trial

Treatment of Tendon Disease Using Autologous Adipose-derived Mesenchymal Stem Cells

Unknown status·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Phase 2·NCT03279796·200 enrolled

Granuloma1 trial

Local Steroid Treatment for Idiopathic Granulomatous Mastitis (LSTIGM)

Unknown status·PPeking Union Medical College Hospital·Phase 4·NCT03766997·100 enrolled

2 more indications

Injury1 trial

Safety and Efficacy of Platelet-Rich Plasma Combined With Compound Betamethasone in Arthroscopic Surgery for Rotator Cuff Injury With Shoulder Adhesion: A Prospective, Multicenter, Randomized Controlled Trial

Recruiting·SSecond Affiliated Hospital of Nanchang University·N/A·NCT07348016·70 enrolled

Sarcoidosis, Pulmonary1 trial

A Prospective, Multi-center, Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis

Not yet recruiting·PPeking Union Medical College Hospital·Preclinical·NCT07668895·126 enrolled

Sources

References

[1]
ClinicalTrials.gov — 10 trial records for Compound betamethasone. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Compound betamethasone compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Compound betamethasone. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: SSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Compound betamethasone

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Q3 2028

Q4 2028

Q1 2031

Trials by Indication[1]

Frozen Shoulder3 trials

Monoclonal2 trials

Arthritis1 trial

Mesenchymal Stem Cells1 trial

Granuloma1 trial

Injury1 trial

Sarcoidosis, Pulmonary1 trial

References

Drug Info

Quick Facts

Related News